Forwarded from Health & Medicine
#DonaldTrump to select #ScottGottlieb, a physician with deep drug-industry ties, to run the #FDA
https://goo.gl/xlALqX
https://goo.gl/xlALqX
Washington Post
Trump to select Scott Gottlieb, a physician with deep drug-industry ties, to run the FDA
Trump's selection for FDA head is likely to shake up the agency but not try to dismantle it.
Jewish News™
#DonaldTrump to select #ScottGottlieb, a physician with deep drug-industry ties, to run the #FDA https://goo.gl/xlALqX
Update: #WhiteHouse official:
#DonaldTrump nominates #ScottGottlieb to head the #FDA
https://t.co/IDZOtiqsk6
#DonaldTrump nominates #ScottGottlieb to head the #FDA
https://t.co/IDZOtiqsk6
Reuters
Live: U.S. Politics
Live U.S. political coverage of President Donald Trump's first 100 days in office.
This media is not supported in your browser
VIEW IN TELEGRAM
FDA proposes mammogram changes for first time in 20 years to identify breast cancer early
The #US Food and Drug Administration proposed new rules Wednesday that will require mammogram centers to tell women more about how dense breast tissue can affect their health and increase their cancer risk. The proposal aims to identify breast cancer risks earlier, amending regulations under the Mammography Quality Standards Act of 1992. "The new proposed rule on mammography will require, for the first time under federal rules, that women receive information about breast density to better inform their healthcare decisions," #FDA Commissioner #ScottGottlieb said in a statement.
Women with dense breasts will be notified that they are at a higher risk of developing breast cancer and that X-ray results aren't always as accurate for them, because tumors can go undetected behind dense tissue. Some states already require centers to provide this information to patients.
The #US Food and Drug Administration proposed new rules Wednesday that will require mammogram centers to tell women more about how dense breast tissue can affect their health and increase their cancer risk. The proposal aims to identify breast cancer risks earlier, amending regulations under the Mammography Quality Standards Act of 1992. "The new proposed rule on mammography will require, for the first time under federal rules, that women receive information about breast density to better inform their healthcare decisions," #FDA Commissioner #ScottGottlieb said in a statement.
Women with dense breasts will be notified that they are at a higher risk of developing breast cancer and that X-ray results aren't always as accurate for them, because tumors can go undetected behind dense tissue. Some states already require centers to provide this information to patients.